Fig. 3From: The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysisForest plot of safety outcomes between anti-VEGF and laserBack to article page